A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear film quality and ocular surface health within days, offering a valuable treatment option for patients with aqueous-deficient dry eye despite no significant changes in tear breakup time.
Sponsored by Novartis US Medical Affairs Elevated lipoprotein(a) (Lp[a]) represents the most common type of genetic dyslipidemia. 1 Elevated Lp(a) levels occurring in 20% of…
Experts cover key updates in the management of patients with Neurofibromatosis Type 1 with Plexiform Neurofibromas, or NF1-PN, while also exploring the pathophysiology of NF1-PN,…
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists’ reluctance to treat children, but increasing their comfort level with…
Zongertinib gains FDA approval for treating HER2-mutated non–small cell lung cancer (NSCLC), offering hope with fewer side effects and promising response rates in patients.
Panelists discuss several promising new agents for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including an LPA1 receptor antagonist showing lung function preservation,…
The FDA approved multiple groundbreaking treatments in July, enhancing options across patient populations.
A new KFF poll found that 55% of adults use social media to find health information, with most of this group comprising young adults and…
Hadar Avihai Lev-Tov, MD, argues that integrating dermatologists into multidisciplinary health care teams is crucial for providing comprehensive patient care.
A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health…
Alina Salganicoff, PhD, discusses the immediate effects of the budget cuts to Medicaid as it pertains to women’s health across the country.
